Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 4 ( July-August, 2022 ) > List of Articles

Original Article

Obstetric Comorbidity Index—A Promising Tool to Predict Maternal Morbidity

Chethana Bolanthakodi, Murali Shankar Bhat, Raghavendra R Huchchannavar

Keywords : Comorbidity, Early diagnosis, High-risk pregnancy, Labor monitoring

Citation Information : Bolanthakodi C, Bhat MS, Huchchannavar RR. Obstetric Comorbidity Index—A Promising Tool to Predict Maternal Morbidity. J South Asian Feder Obs Gynae 2022; 14 (4):393-399.

DOI: 10.5005/jp-journals-10006-2101

License: CC BY-NC 4.0

Published Online: 22-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Introduction: In India's immense population, the maternal mortality ratio in 2016–2018 was 113. We are still away from the sustainable development goals (SDGs) of MMR less than 70 per 100,000 live births set by the United Nations.1 In obstetric patients, due to the occasional occurrence of critical conditions, it is hard to identify the initial signs of grievous illness. Focusing on mothers whose comorbidities place them at risk of severe maternal morbidity is a strategy for risk reduction. The obstetric comorbidity index (OB-CMI) is one such tool that summarizes the burden of maternal comorbidities with a quantified approach. Aim: To evaluate the performance of OB-CMI in identifying women at risk of severe maternal morbidity (SMM) during labor. Material and methods: We did a retrospective analysis of hospital records of pregnant women >28 weeks gestation admitted to the labor room, in labor, or planned for delivery (January–June 2019). On admission, the OB-CMI was calculated for each patient based on history, examination, and investigations. Any SMM (ACOG and Society for Maternal-Fetal Medicine consensus definition) experienced before discharge was recorded. Association between OB-CMI and SMM was analyzed. Results: Out of the 1678 women included in the study, 36 women experienced SMM (2.1%). The OB-CMI ranged from 0 to 10, with a median of 0. The median of patients experiencing SMM was 5 as compared to 0 in those who did not (p <0.000). For every 1-point increase in the score, patients experienced a 2.02 increase in odds of severe maternal morbidity (95% confidence interval, 1.75–2.34). The ROC analysis revealed good discrimination between OB-CMI and SMM (0.841, 95% confidence interval 0.752–0.930). Conclusion: The prevention of SMM is a priority and OB-CMI is a clinically valid tool to identify women at risk during delivery. It is useful as a screening tool, for triaging high-risk patients in specialized institutions that are well equipped. It could also complement physiologic-based screening tools and help in early intervention.

PDF Share
  1. Special Bulletin on Maternal Mortality in India 2016-2018 Sample Registration System Office of the Registrar General, India, July 2020. Available from:
  2. Mhyre JM, D’Oria R, Hameed AB, et al. The maternal early warning criteria: a proposal from the national partnership for maternal safety. Obstet Gynecol 2014;124(4):782–786. DOI: 10.1097/AOG.0000000000000480.
  3. Singh A, Guleria K, Vaid NB, et al. Evaluation of maternal early obstetric warning system (MEOWS chart) as a predictor of obstetric morbidity: a prospective observational study. Eur J Obstet Gynecol Reprod Biol 2016;207:11–17. DOI: 10.1016/j.ejogrb.2016.09.014.
  4. Macones GA. Understanding and reducing serious maternal morbidity: a step in the right direction. Obstet Gynecol 2013;122(5):945–946. DOI: 10.1097/01.AOG.0000435079.10951.5f.
  5. Bateman BT, Mhyre JM, Hernandez-Diaz S, et al. Development of a comorbidity index for use in obstetric patients. Obstet Gynecol 2013;122(5):957–965. DOI: 10.1097/AOG.0b013e3182a603bb.
  6. Metcalfe A, Lix LM, Johnson JA, et al. Validation of an obstetric comorbidity index in an external population. BJOG 2015;122(13):1748–1755. DOI: 10.1111/1471-0528.13254.
  7. Obstetric Care Consensus No. 5. Severe maternal morbidity: screening and review. Obstet Gynecol 2016;128(3):e54-e60. DOI: 10.1097/AOG.0000000000001642.
  8. Einav S, Bromiker R, Sela HY. Maternal critical illness. Curr Anesthesiol Rep 2017;7(1):55–66. DOI: 10.1007/s40140-017-0198-5.
  9. Geller SE, Adams MG, Kominiarek MA, et al. Reliability of a preventability model in maternal death and morbidity. Am J Obstet Gynecol 2007;196(1):57.e1–57.e6. DOI: 10.1016/j.ajog.2006.07.052.
  10. Easter SR, Bateman BT, Sweeney VH, et al. Comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery. Am J Obstet Gynecol 2019;221(3):271.e1–271.e10. DOI: 10.1016/j.ajog.2019.06.025.
  11. Aoyama K, D’Souza R, Inada E, et al. Measurement properties of comorbidity indices in maternal health research: a systematic review. BMC Pregnancy and Childbirth 2017;17:372. DOI 10.1186/s12884-017-1558-3.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.